Skip to the page
pepts.wiki

We are not doctors and nothing here is medical advice. Always consult a medical professional first. Why we say this

Studied in peopleStub

GHRP-6

Ghrelin receptor agonist

One of the first synthetic growth hormone releasing peptides, acting through the ghrelin receptor.

Reconstitution calculator

At a glance

Studied in people

There are published studies in people. It is not a licensed medicine in the United States or the European Union.

This page is a stub

The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.

How strong is the evidence

How far it has climbed

Every medicine climbs the same ladder. Most compounds never reach the top, and where one stands says how much its claims can carry.

  1. Licensed medicine

    A regulator has reviewed the trials and licensed it for a named use.

  2. Phase 3

    Large randomized trials, often thousands of people, against placebo or a standard treatment.

  3. Phase 2

    Mid-sized trials that measure dose against effect in people with the condition.

  4. Phase 1 and early human studies: GHRP-6

    First studies in people: safety, and how the body handles it.

  5. Cells and animals

    Laboratory and animal work. An animal result is not a result in people.

639
papers on PubMed
234
of them in people
19
randomized trials
28
reviews

A count says how much has been published, not what it found. Counted on PubMed: 2026-11-16

Handling and reconstitution

From powder to a measured sample

The same four steps for any lyophilized vial. Laboratory handling, not use in a person.

  1. 1. Read the vial

    The label gives the mass of peptide in the vial, in milligrams. That number is the start of every calculation.

  2. 2. Add the diluent

    A measured volume of diluent goes in slowly, down the glass. Swirl gently; shaking can damage a peptide.

  3. 3. Work out the strength

    Concentration is mass divided by volume: 10 mg in 2 mL is 5 mg per mL.

  4. 4. Measure the sample

    Volume is the mass wanted divided by the concentration. On a U-100 syringe, 1 mL is 100 units.

The calculator below does the arithmetic and shows its working.

As powder

General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.

In solution

Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.

This is general practice for lyophilized peptides, not data on GHRP-6 itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage

Reconstitution calculator

Opens on vial sizes common for research peptides. Change any number. How the arithmetic works

Draw to

10 units

0.1 mL on a U-100 syringe

Concentration
2.5 mg/mL
Each unit holds
25 mcg
Samples in the vial
20
Sample
250 mcg

5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of GHRP-6; no amount here is a recommendation.

GHRP-6: on PubMed

What PubMed held for GHRP-6 on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.

639
papers
234
in humans
42
clinical trials
19
randomized trials
2012: 35 papers122013: 30 papers2014: 34 papers142015: 29 papers2016: 24 papers162017: 22 papers2018: 20 papers182019: 24 papers2020: 16 papers202021: 19 papers2022: 13 papers222023: 11 papers2024: 10 papers242025: 14 papers2026: 11 papers so far26
Papers per year, 2012 to 2026. The most in one year: 35.

Most relevant on PubMed

Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.

  1. Bombesin-like peptides stimulate growth hormone secretion mediated by the gastrin-releasing peptide receptor in cattle

    Randomized trialZhao H, Matsuda S, Thanthan S, et al. Peptides, 2012. PMID 22868212

  2. Ghrelin and GHRP-6-induced ACTH and cortisol release in thyrotoxicosis

    StudyNascif SO, Molica P, Correa-Silva SR, et al. Pituitary, 2009. PMID 19396632

  3. Insulinotropic action of bombesin-like peptides mediated by gastrin-releasing peptide receptors in steers

    Randomized trialZhao HQ, Yao G, Yannaing S, et al. Journal of animal science, 2016. PMID 26812312

  4. Growth hormone response to GHRH + GHRP-6 in type 2 diabetes during euglycemic and hyperglycemic clamp

    TrialMicic D, Kendereski A, Sumarac-Dumanovic M, et al. Diabetes research and clinical practice, 2004. PMID 14693411

  5. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression

    TrialCordido F, Peino R, Peñalva A, et al. The Journal of clinical endocrinology and metabolism, 1996. PMID 8772550

  6. The effect of an opiate antagonist on the hormonal changes induced by hexarelin

    Randomized trialKorbonits M, Trainer PJ, Besser GM Clinical endocrinology, 1995. PMID 7586608

  7. N-aminoimidazolidin-2-one peptidomimetics

    StudyDoan ND, Hopewell R, Lubell WD Organic letters, 2014. PMID 24697286

  8. Calorie restriction activates a gastric Notch-FOXO1 pathway to expand ghrelin cells

    StudyMcKimpson WM, Spiegel S, Mukhanova M, et al. The Journal of cell biology, 2024. PMID 38958606

Search used: ("GHRP-6"[tiab]). Run it on PubMed

Research links

Also in GH axis

Sold in blends: GHRP-2 + GHRP-6 + CJC-1295 (No DAC)